AGL

agilon health, inc. (AGL) PESTLE Analysis Analysis (2026)

Invetso Score: 5/10 — Balanced · Last Updated: 2026-08-01

Overall Score

Political

No material political developments were provided this month.

Economic

AGL continues to screen as a low-multiple, distressed earnings profile with negative TTM margins and cash flow, despite a modest current ratio of 1.08.

Valuation remains inexpensive on sales and enterprise value, but the negative free cash flow yield and weak profitability keep the economic backdrop challenged.

Social

No new social or customer-demand developments were provided this month.

Technological

No material technology or product developments were provided this month.

Legal

No new litigation, regulatory, or compliance developments were provided this month.

Environmental

No new environmental or sustainability developments were provided this month.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on agilon health, inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →